Assignee
AKAGERA MEDICINES INC
US·8 granted patents·9 pending applications·24 citations·filing 2021–2025
Top patents by PatentIndex Score
17 records- 0197US12077725B2Ionizable cationic lipidsAKAGERA MEDICINES INC·Filed 2022·Granted Sep 3, 2024·4 cites·20 claims
- 0297US11591544B2Ionizable cationic lipidsAKAGERA MEDICINES INC·Filed 2021·Granted Feb 28, 2023·7 cites·16 claims
- 0396US12064479B2Lipid nanoparticles for delivery of nucleic acids and methods of use thereofAKAGERA MEDICINES INC·Filed 2023·Granted Aug 20, 2024·5 cites·28 claims
- 0496US11566023B2Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereofAKAGERA MEDICINES INC·Filed 2022·Granted Jan 31, 2023·3 cites·20 claims
- 0596US11555033B2Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereofAKAGERA MEDICINES INC·Filed 2021·Granted Jan 17, 2023·4 cites·26 claims
- 0691US12331264B2Lipid nanoparticles for delivery of nucleic acids and methods of use thereofAKAGERA MEDICINES INC·Filed 2022·Granted Jun 17, 2025·1 cites·20 claims
- 0787US2024425495A1Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereofAKAGERA MEDICINES INC·Filed 2024·Application pending·0 cites
- 0887US2024425494A1Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereofAKAGERA MEDICINES INC·Filed 2024·Application pending·0 cites
- 0984US2026077038A1Lipid nanoparticles for delivery of nucleic acids and methods of use thereofAKAGERA MEDICINES INC·Filed 2025·Application pending·0 cites
- 1083US12145928B2Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereofAKAGERA MEDICINES INC·Filed 2022·Granted Nov 19, 2024·0 cites·15 claims
- 1182US12116361B2Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereofAKAGERA MEDICINES INC·Filed 2022·Granted Oct 15, 2024·0 cites·10 claims
- 1282US2024325525A1Lipid Nanoparticles for Delivery of Nucleic Acids and Methods of Use ThereofAKAGERA MEDICINES INC·Filed 2024·Application pending·0 cites
- 1380US2026055335A1Ionizable cationic lipid compoundsAKAGERA MEDICINES INC·Filed 2025·Application pending·0 cites
- 1477US2026083674A1Oxazolidinone liposome compositionsAKAGERA MEDICINES INC·Filed 2025·Application pending·0 cites
- 1568US2025064739A1Oxazolidinone liposome compositionsAKAGERA MEDICINES INC·Filed 2022·Application pending·0 cites
- 1656US2026007741A1Lipid nanoparticles for delivery of nucleic acids and vaccinesAKAGERA MEDICINES INC·Filed 2025·Application pending·0 cites
- 1756US2025387462A1Lipid nanoparticles for delivery of nucleic acids and vaccine for the prevention of tuberculosis or other mycobacterial infectionsAKAGERA MEDICINES INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AKAGERA MEDICINES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →